The serum IL-1β, IL-6, and TNF-α levels were significantly reduced, whereas IL-10 was greatly increased in mice with early and advanced atherosclerosis after GLSP treatment (Figure 3A-B). This evidence concerns the gene IL1B and atherosclerosis.